← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2023-1:988 | 988 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-4 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:988 | 988 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:988 | 988 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1304 | 72934-1304-2 | Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:988 | 988 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-5030 | 70214-5030-1 | Oxytocin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:988 | 988 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:988 | 988 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:988 | 988 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:989 | 989 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5465 | 26436-5465-3 | Estriol 10mg DHEA10mg/gm | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:989 | 989 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2082 | 71286-2082-2 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:989 | 989 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0422 | 71285-0422-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:989 | 989 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6147 | 72196-6147-1 | Magnesium Sulfate Heptahydrate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:989 | 989 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Megestrol Acetate | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:989 | 989 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0790 | 5446-0790-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:989 | 989 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:989 | 989 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-118 | 73702-118-03 | Norepinephrine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:989 | 989 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1372 | 61141-1372-5 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:989 | 989 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-1 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:989 | 989 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-517 | 70092-517-43 | Morphine Sulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:989 | 989 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2300 | 72934-2300-2 | Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:989 | 989 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-0903 | 60652-0903-1 | Oxytocin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:989 | 989 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:989 | 989 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:989 | 989 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:990 | 990 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1016 | 73013-1016-1 | Fentanyl Citrate 2.5mg added to 250mL NS Bag | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:990 | 990 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2082 | 71286-2082-1 | Fentanyl Citrate | 2019-1 | valid | 0 | 2026-10-17 | |
outsourcing:2019-2:990 | 990 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0415 | 72196-0415-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:990 | 990 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6148 | 72196-6148-1 | Magnesium Sulfate Heptahydrate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:990 | 990 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-881 | 72833-881-01 | Metformin Hydrochloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:990 | 990 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0407 | 5446-0407-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:990 | 990 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:990 | 990 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-116 | 73702-116-03 | Norepinephrine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:990 | 990 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:990 | 990 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-380 | 70092-380-36 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:990 | 990 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-380 | 70092-380-36 | Morphine Sulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:990 | 990 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2304 | 72934-2304-2 | Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:990 | 990 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5103 | 71266-5103-1 | Oxytocin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:990 | 990 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5103 | 71266-5103-1 | Oxytocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:990 | 990 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:990 | 990 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:991 | 991 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5623 | 26436-5623-4 | Biest 50/50 0.45mg/testosterone 0.4mg/gm | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:991 | 991 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:991 | 991 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0430 | 71285-0430-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:991 | 991 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6048 | 72196-6048-1 | Magnesium Sulfate Heptahydrate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:991 | 991 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1241 | 5446-1241-01 | Methacholine Chloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:991 | 991 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0408 | 5446-0408-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:991 | 991 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1647 | 5446-1647-01 | Lidocaine; Tetracaine | 2021-2 | valid | 0 | 2026-10-17 | |
outsourcing:2022-1:991 | 991 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-115 | 73702-115-03 | Norepinephrine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:991 | 991 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:991 | 991 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-518 | 70092-518-75 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:991 | 991 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-133 | 70092-133-43 | Morphine Sulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:991 | 991 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2306 | 72934-2306-2 | Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:991 | 991 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5000 | 71266-5000-1 | Oxytocin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:991 | 991 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0903 | 83863-0903-1 | Oxytocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:991 | 991 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:991 | 991 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:992 | 992 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69389-064 | 69389-064-22 | Sarracenia Purpurea | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:992 | 992 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:992 | 992 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0415 | 71285-0415-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:992 | 992 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-731 | 70004-731-30 | Magnesium Sulfate Heptahydrate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:992 | 992 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1249 | 5446-1249-01 | Methacholine Chloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:992 | 992 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1018 | 5446-1018-10 | Lidocaine; Prilocaine Hydrochloride; Tetracaine Hydrochloride; Phenylephrine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:992 | 992 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:992 | 992 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-119 | 73702-119-03 | Norepinephrine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:992 | 992 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:992 | 992 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-520 | 70092-520-49 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:992 | 992 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-522 | 70092-522-35 | Morphine Sulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:992 | 992 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2309 | 72934-2309-2 | Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:992 | 992 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5100 | 71266-5100-1 | Oxytocin | 2024-2 | valid | 0 | 2026-10-17 | |
outsourcing:2025-1:992 | 992 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2025-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-2:992 | 992 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:992 | 992 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-485 | 70092-485-46 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:993 | 993 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-294 | 70092-294-74 | Hydromorph PF 1 mg/ml 50ml NS CADD FSFF | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:993 | 993 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:993 | 993 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0422 | 72196-0422-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:993 | 993 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6147 | 71285-6147-1 | Magnesium Sulfate Heptahydrate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:993 | 993 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1247 | 5446-1247-01 | Methacholine Chloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:993 | 993 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0863 | 5446-0863-01 | Lidocaine; Racepinephrine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:993 | 993 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:993 | 993 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-114 | 73702-114-03 | Norepinephrine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:993 | 993 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Neostigmine Methylsulfate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:993 | 993 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2467 | 72907-2467-1 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:993 | 993 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-518 | 70092-518-75 | Morphine Sulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:993 | 993 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2307 | 72934-2307-2 | Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:993 | 993 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:993 | 993 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0012 | 71139-0012-1 | Oxytocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:993 | 993 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:993 | 993 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:994 | 994 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-523 | 70092-523-50 | Morphine 1 mg/ml 50 ml NS syr | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:994 | 994 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:994 | 994 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0416 | 72196-0416-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:994 | 994 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6087 | 71285-6087-1 | Magnesium Sulfate Heptahydrate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:994 | 994 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1248 | 5446-1248-01 | Methacholine Chloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:994 | 994 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1268 | 5446-1268-01 | Lidocaine; Racepinephrine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:994 | 994 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:994 | 994 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-550 | 71170-550-25 | Norepinephrine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:994 | 994 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-53 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:994 | 994 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-3 | Morphine Sulfate | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:994 | 994 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-520 | 70092-520-49 | Morphine Sulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:994 | 994 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2308 | 72934-2308-2 | Niacinamide; Tretinoin | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:994 | 994 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:994 | 994 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-012 | 68985-012-93 | Oxytocin | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:994 | 994 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:994 | 994 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:995 | 995 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2615 | 72934-2615-2 | Domela | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:995 | 995 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:995 | 995 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0425 | 71285-0425-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:995 | 995 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6148 | 71285-6148-1 | Magnesium Sulfate Heptahydrate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:995 | 995 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1246 | 5446-1246-01 | Methacholine Chloride | 2020-2 | valid | 0 | 2026-10-17 | |
outsourcing:2021-1:995 | 995 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0607 | 5446-0607-01 | Lidocaine; Racepinephrine; Tetracaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:995 | 995 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:995 | 995 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-510 | 71170-510-25 | Norepinephrine | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:995 | 995 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-113 | 73702-113-15 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:995 | 995 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:995 | 995 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72907-2467 | 72907-2467-1 | Morphine Sulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:995 | 995 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-5040 | 70214-5040-1 | Norepinephrine | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:995 | 995 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:995 | 995 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5007 | 26436-5007-3 | Panthenol | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:995 | 995 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:995 | 995 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-042 | 70092-042-05 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:996 | 996 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-6100 | 79559-6100-1 | S-TT100 | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:996 | 996 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:996 | 996 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0408 | 71285-0408-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:996 | 996 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6048 | 71285-6048-1 | Magnesium Sulfate Heptahydrate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:996 | 996 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:996 | 996 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:996 | 996 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:996 | 996 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:996 | 996 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-6065 | 72196-6065-1 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:996 | 996 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-097 | 71449-097-42 | Moxifloxacin Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:996 | 996 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:996 | 996 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-550 | 71170-550-25 | Norepinephrine | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:996 | 996 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:996 | 996 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5112 | 26436-5112-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:996 | 996 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:996 | 996 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-046 | 70092-046-46 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:997 | 997 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5160 | 71266-5160-2 | Phenylephrine HCl | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:997 | 997 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:997 | 997 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0408 | 72196-0408-1 | Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:997 | 997 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7080 | 71285-7080-1 | Magnesium Sulfate Heptahydrate | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:997 | 997 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:997 | 997 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-3102 | 72627-3102-1 | Lidocaine; Tetracaine | 2021-1 | valid | 0 | 2026-10-17 | |
outsourcing:2021-2:997 | 997 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:997 | 997 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-007 | 72055-007-01 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:997 | 997 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-103 | 71449-103-11 | Neostigmine Methylsulfate | 2022-2 | valid | 0 | 2026-10-17 | |
outsourcing:2023-1:997 | 997 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-501 | 81375-501-01 | Moxifloxacin Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:997 | 997 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:997 | 997 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:997 | 997 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:997 | 997 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5137 | 26436-5137-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:997 | 997 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:997 | 997 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:998 | 998 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-523 | 70092-523-50 | Morphine PF 1 mg/ml 50 ml NS syr | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:998 | 998 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:998 | 998 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0406 | 72196-0406-1 | Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:998 | 998 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0301 | 71285-0301-1 | Magnesium Sulfate Heptahydrate; Dextrose Monohydrate; Trisodium Citrate Dihydrate; Sodium Chloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:998 | 998 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:998 | 998 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:998 | 998 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:998 | 998 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-006 | 72055-006-01 | Norepinephrine Bitartrate | 2022-1 | valid | 0 | 2026-10-17 | |
outsourcing:2022-2:998 | 998 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:998 | 998 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-505 | 81375-505-01 | Moxifloxacin Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:998 | 998 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Morphine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-1:998 | 998 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:998 | 998 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:998 | 998 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5497 | 26436-5497-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:998 | 998 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:998 | 998 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phenylephrine Hydrochloride | 2026-1 | source_no_ndc | 1 | 2026-10-17 | |||
compounder:999 | 999 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8241 | 71266-8241-1 | Tropicamide 1%, Cyclopentolate 1%, Phenylephrine 10%, Ketorolac 0.5% | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:999 | 999 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:999 | 999 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0406 | 71285-0406-1 | Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:999 | 999 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0214 | 71285-0214-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:999 | 999 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methadone Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:999 | 999 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:999 | 999 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:999 | 999 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:999 | 999 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:999 | 999 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Moxifloxacin Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-2:999 | 999 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2040 | 71286-2040-4 | Morphine Sulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:999 | 999 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-027 | 71506-027-58 | Norepinephrine Bitartrate | 2024-1 | valid | 0 | 2026-10-17 | |
outsourcing:2024-2:999 | 999 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:999 | 999 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5097 | 26436-5097-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:999 | 999 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:999 | 999 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-978 | 69194-978-10 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1000 | 1000 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9015 | 71266-9015-3 | Glycopyrrolate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:1000 | 1000 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2019-2:1000 | 1000 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-988 | 69374-988-10 | Lysine Hydrochloride; Arginine Hydrochloride | 2019-2 | valid | 0 | 2026-10-17 | |
outsourcing:2020-1:1000 | 1000 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0215 | 71285-0215-1 | Magnesium Sulfate Heptahydrate; Sodium Chloride; Potassium Chloride | 2020-1 | valid | 0 | 2026-10-17 | |
outsourcing:2020-2:1000 | 1000 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Methazolamide | 2020-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-1:1000 | 1000 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2021-2:1000 | 1000 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Lidocaine; Tetracaine | 2021-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-1:1000 | 1000 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2022-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2022-2:1000 | 1000 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2023-1:1000 | 1000 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-8604 | 71266-8604-1 | Moxifloxacin Hydrochloride | 2023-1 | valid | 0 | 2026-10-17 | |
outsourcing:2023-2:1000 | 1000 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-613 | 70092-613-79 | Morphine Sulfate | 2023-2 | valid | 0 | 2026-10-17 | |
outsourcing:2024-1:1000 | 1000 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Norepinephrine Bitartrate | 2024-1 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2024-2:1000 | 1000 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Oxytocin | 2024-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2025-1:1000 | 1000 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5641 | 26436-5641-5 | Papaverine Hydrochloride; Alprostadil; Phentolamine Mesylate | 2025-1 | valid | 0 | 2026-10-17 | |
outsourcing:2025-2:1000 | 1000 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-17 | |||
outsourcing:2026-1:1000 | 1000 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-980 | 69194-980-10 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-10-17 | |
compounder:1001 | 1001 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3706 | 72682-3706-1 | Estradiol 6mg | 2025-2 | valid | 0 | 2026-09-18 |